3 results
Approved WMOCompleted
To increase progression-free survival at 3 months.
Approved WMOCompleted
The purpose of the study is to determine the PK profile of three different intranasal testosterone formulations.
Approved WMOCompleted
See protocol P5:The primary objective of this study is to evaluate the efficacy of 12 months of oral ACH-0144471 in participants with C3G or ICMPGNbased on histologic scoring and proteinuriaThe secondary objectives of this study are: * To evaluate…